No Lasting Lung Damage After Full Recovery From COVID-19

Deutschland Nachrichten Nachrichten

No Lasting Lung Damage After Full Recovery From COVID-19
Deutschland Neuesten Nachrichten,Deutschland Schlagzeilen
  • 📰 WebMD
  • ⏱ Reading Time:
  • 11 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 51%

A new study suggests that lung damage doesn't last in people who've recovered from COVID-19.

In all of the patients, benign lung tissue from around the nodules or tumors showed no detectable lasting lung damage that was directly linked to COVID-19., a big question has been whether COVID-19 will have long-term or permanent damage on our lungs," said senior study author Dr. Zaid Abdelsattar, a thoracic and cardiovascular surgeon at Loyola Medicine, in Maywood, Ill.

"This research provided us with the rare opportunity to study the asymptomatic survivors of COVID-19 and make observations to help us answer this question," he said in a Loyola news release.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

WebMD /  🏆 709. in US

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Welcome! You are invited to join a meeting: Conversaciones Comunitarias de COVID-19 y la Vacuna de COVID-19 | Community Conversations about COVID-19 and the COVID-19 Vaccine. After registering, you will receive a confirmation email about joining the meeting.Welcome! You are invited to join a meeting: Conversaciones Comunitarias de COVID-19 y la Vacuna de COVID-19 | Community Conversations about COVID-19 and the COVID-19 Vaccine. After registering, you will receive a confirmation email about joining the meeting.
Weiterlesen »

AstraZeneca’s Covid-19 Antibody Therapy Effective In Preventing Symptoms Among High-Risk Groups, Trial FindsAstraZeneca’s Covid-19 Antibody Therapy Effective In Preventing Symptoms Among High-Risk Groups, Trial FindsAstraZeneca’s treatment may offer additional protection to vulnerable groups who fail to generate a strong immune response through vaccines.
Weiterlesen »

Texas health officials warn of full ICUs as state grapples with worsening Covid-19 surgeTexas health officials warn of full ICUs as state grapples with worsening Covid-19 surgeTexas health officials say the state is in 'one of its worst fights' as Covid-19 hospitalizations rise and leaders and local districts defy safety measures
Weiterlesen »

How might the return to classrooms affect covid-19 transmission?How might the return to classrooms affect covid-19 transmission?With adults vaccinated, children—and classrooms—may become a more prominent source of infections | The Economist explains
Weiterlesen »

Sydney tightens COVID-19 curbs, lockdown extended through SeptemberSydney tightens COVID-19 curbs, lockdown extended through SeptemberAustralian authorities on Friday extended a COVID-19 lockdown in Sydney until the end of September and introduced a night curfew in the city's worst-affected suburbs, after nearly two months of curbs failed to contain an outbreak of the Delta variant.
Weiterlesen »



Render Time: 2025-04-19 05:56:32